VMI
VHCP Management II Portfolio holdings
AUM
$379M
This Quarter Return
+21.92%
1 Year Return
+424.39%
3 Year Return
+2,335.22%
5 Year Return
–
10 Year Return
–
AUM
$374M
AUM Growth
+$374M
(+12%)
Cap. Flow
+$6.39M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
86.42%
Holding
21
New
3
Increased
2
Reduced
3
Closed
–
Top Buys
1 |
KalVista Pharmaceuticals
KALV
|
$16.8M |
2 |
BioCryst Pharmaceuticals
BCRX
|
$5.99M |
3 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$4.89M |
4 |
MTVA
MetaVia Inc. Common Stock
MTVA
|
$1.06M |
5 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$520K |
Top Sells
1 |
argenx
ARGX
|
$17M |
2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$4.27M |
3 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$1.58M |
Sector Composition
1 | Healthcare | 97.66% |